4.8 Article

Regulation of BMP4/Dpp retrotranslocation and signaling by deglycosylation

期刊

ELIFE
卷 9, 期 -, 页码 -

出版社

ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.55596

关键词

-

类别

资金

  1. Grace Science Foundation
  2. National Institutes of Health [R35GM130317]
  3. H2020 Marie Sklodowska-Curie Actions [844147]
  4. Private Foundation in Italy
  5. Fondazione AIRC per la Ricerca sul Cancro [20661]
  6. Worldwide Cancer Research [18-0399]
  7. Japan Society for the Promotion of Science
  8. University of Basel
  9. SNSF Ambizione [PZ00P3_180019]
  10. Swiss National Science Foundation (SNF) [PZ00P3_180019] Funding Source: Swiss National Science Foundation (SNF)
  11. Marie Curie Actions (MSCA) [844147] Funding Source: Marie Curie Actions (MSCA)

向作者/读者索取更多资源

During endoplasmic reticulum-associated degradation (ERAD), the cytoplasmic enzyme N-glycanase 1 (NGLY1) is proposed to remove N-glycans from misfolded N-glycoproteins after their retrotranslocation from the ER to the cytosol. We previously reported that NGLY1 regulates Drosophila BMP signaling in a tissue-specific manner (Galeone et al., 2017). Here, we establish the Drosophila Dpp and its mouse ortholog BMP4 as biologically relevant targets of NGLY1 and find, unexpectedly, that NGLY1-mediated deglycosylation of misfolded BMP4 is required for its retrotranslocation. Accumulation of misfolded BMP4 in the ER results in ER stress and prompts the ER recruitment of NGLY1. The ER-associated NGLY1 then deglycosylates misfolded BMP4 molecules to promote their retrotranslocation and proteasomal degradation, thereby allowing properly-folded BMP4 molecules to proceed through the secretory pathway and activate signaling in other cells. Our study redefines the role of NGLY1 during ERAD and suggests that impaired BMP4 signaling might underlie some of the NGLY1 deficiency patient phenotypes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据